Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Saraswanti Indoland Development Tbk. (SWID) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs Saraswanti Indoland Development Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 319B, 7.6K 24h volume), while Saraswanti Indoland Development Tbk. trades at Rp109 (market cap 608.51B, 10.97M 24h volume). The key difference: Saraswanti Indoland Development Tbk. is the larger of the two by market cap, and Saraswanti Indoland Development Tbk. is more actively traded (10.97M versus 7.6K). Which is the better fit depends on your goals.
| DGNS | SWID | |
|---|---|---|
Market Cap | 319B | 608.51B |
Volume | 7.6K | 10.97M |
Lot | 76 | 109.7K |
Turnover | 1.74M | 1.21B |
Average Price | 229.21 | 110.22 |
Value | 1.74M | 1.21B |
Indicative Equilibrium Price | 232 | 114 |
Indicative Equilibrium Volume | 200 | 1.97K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About Saraswanti Indoland Development Tbk.
PT Saraswanti Indoland Development Tbk ( The Company) was established on August 2, 2010 based on the Deed of Notary Ismaryani, SH, MKn. Number : 01. The deed of establishment of the Company was approved by the Minister of Law and Human Rights of the Republic of Indonesia number: AHU41610.AH.01.01.Tahun 2010. The Company started its commercial operations in 2011.
Read more on SWID →
